MP Biomedicals™ Mycoplasma Removal Agent (MRA)

Mycoplasma Removal Agent (MRA) is a derivative of the quinoline family of antibiotics and eliminates mycoplasma contamination in cell cultures by inhibiting mycoplasma DNA gyrase.

Supplier:  MP Biomedicals™ 093050044

Catalog No. ICN3050044

Description

• Derivative of the quinoline family of antibiotics and eliminates mycoplasma infection by inhibiting mycoplasma DNA gyrase
• Supplied as a ready-to-use solution
• Cited by the European Collection of Animal Cell Cultures (Porton Down, U.K.) as being superior to all other current products for the eradication of mycoplasma
• Cell toxicity is low following treatment at the recommended concentration of 0.5 μg/mL
• Eliminates multiple mycoplasma species within one week using the lowest dosage
• Prevents recontamination of the culture at 0.1 μg/mL
• Maintains cell viability
• Compatible with most mammalian cell lines
• Sterility and low cytotoxicity

Specifications

• Content And Storage: Store at Room Temperature (15 to 30°C). Protect from light.
• Form: Clear, light yellow solution
• Sterility: Sterile
• Quantity: 5 mL

• Concentration: 50 µg/mL
• Product Type: Mycoplasma Removal
• For Use With (Application): Mycoplasma elimination